Pages that link to "Q34263558"

The following pages link to Phosphoryltyrosyl mimetics in the design of peptide-based signal transduction inhibitors (Q34263558):

Displaying 28 items.

• The consequences of selective inhibition of signal transducer and activator of transcription 3 (STAT3) tyrosine705 phosphorylation by phosphopeptide mimetic prodrugs targeting the Src homology 2 (SH2) domain (Q26861758) (← links)
• Discovery of a New Phosphotyrosine Mimetic for PTP1B Using Breakaway Tethering (Q27641159) (← links)
• Discovery and Structure−Activity Relationship of Oxalylarylaminobenzoic Acids as Inhibitors of Protein Tyrosine Phosphatase 1B (Q27641255) (← links)
• Selective Targeting of Disease-Relevant Protein Binding Domains byO-Phosphorylated Natural Product Derivatives (Q27671116) (← links)
• A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells (Q30492764) (← links)
• Design and synthesis of phosphotyrosine mimetics. (Q33187230) (← links)
• Synthesis of phosphatase-stable, cell-permeable peptidomimetic prodrugs that target the SH2 domain of Stat3 (Q33718067) (← links)
• CP27 function is necessary for cell survival and differentiation during tooth morphogenesis in organ culture (Q34126986) (← links)
• Dimeric switch of Hakai-truncated monomers during substrate recognition: insights from solution studies and NMR structure (Q34170693) (← links)
• Structural biology in drug design: selective protein kinase inhibitors (Q34669625) (← links)
• Recent advances in protein tyrosine phosphatase 1B inhibitors (Q35688217) (← links)
• Filarial nematode secreted product ES-62 is an anti-inflammatory agent: therapeutic potential of small molecule derivatives and ES-62 peptide mimetics (Q36478837) (← links)
• Efficient delivery of cell impermeable phosphopeptides by a cyclic peptide amphiphile containing tryptophan and arginine (Q36841273) (← links)
• Synthesis and evaluation of tripodal peptide analogues for cellular delivery of phosphopeptides (Q36883621) (← links)
• Development of Grb2 SH2 Domain Signaling Antagonists: A Potential New Class of Antiproliferative Agents (Q37183974) (← links)
• Synthesis and evaluation of phosphopeptides containing iminodiacetate groups as binding ligands of the Src SH2 domain (Q37367562) (← links)
• The therapeutic potential of the filarial nematode-derived immunodulator, ES-62 in inflammatory disease (Q37646847) (← links)
• Genistein inhibits invasive potential of human hepatocellular carcinoma by altering cell cycle, apoptosis, and angiogenesis (Q40327067) (← links)
• Tripeptide inhibitors of Yersinia protein-tyrosine phosphatase (Q41466295) (← links)
• Peptidic α-Ketocarboxylic Acids and Sulfonamides as Inhibitors of Protein Tyrosine Phosphatases (Q41467626) (← links)
• Structure-based drug design and AutoDock study of potential protein tyrosine kinase inhibitors (Q42038092) (← links)
• The difluoromethylenesulfonic acid group as a monoanionic phosphate surrogate for obtaining PTP1B inhibitors (Q43976130) (← links)
• Design and synthesis of a beta-amino phosphotyrosyl mimetic suitably protected for peptide synthesis (Q44207156) (← links)
• Structure-based design of novel nonpeptide inhibitors of the Src SH2 domain:phosphotyrosine mimetics exploiting multifunctional group replacement chemistry (Q44781106) (← links)
• Cellular stability of serotonin N-acetyltransferase conferred by phosphonodifluoromethylene alanine (Pfa) substitution for Ser-205. (Q45211567) (← links)
• Benzoylphosphonate-based photoactive phosphopeptide mimetics for modulation of protein tyrosine phosphatases and highly specific labeling of SH2 domains. (Q52887160) (← links)
• Identification of a potent inhibitor of human dual-specific phosphatase, VHR, from computer-aided and NMR-based screening to cellular effects. (Q53522193) (← links)
• Stafia-1: a STAT5a-Selective Inhibitor Developed via Docking-Based Screening of in Silico O-Phosphorylated Fragments (Q90019171) (← links)